An AI model is capable of predicting the risk of a thousand diseases

An artificial intelligence (AI) tool can predict the probability of more than 1,000 diseases based on a person's medical history, with greater accuracy than existing technologies, which focus on fewer pathologies, according to the authors in Nature. This model, called Delphi-2M, is also capable of simulating health trajectories for up to 20 years. The tool was trained with health data from 400,000 people in the United Kingdom and tested using data from nearly two million people in Denmark.

17/09/2025 - 17:00 CEST
Expert reactions

250917 Delphi-2M Gustavo EN

Gustavo Sudre

Professor of Genomic Neuroimaging and Artificial Intelligence at King’s College London and Rosetrees Pears Chair of Bioinformatics

Science Media Centre UK

This research looks to be a significant step towards scalable, interpretable, and – most importantly – ethically responsible form of predictive modelling in medicine. The clear demonstration of how explainable AI can be used to model predictions is crucial if this technology is to be utilised in clinical practices, and suggests it may be possible to identify high risk individuals in need of intervention. 

While the current version relies solely on anonymized clinical records, it’s encouraging to see that the model architecture has been deliberately designed to accommodate richer data types, such as biomarkers, imaging, and even genomics. With these future integrations, the Delphi platform is well-positioned to evolve into a truly multimodal, precision-medicine tool.

The author has declared they have no conflicts of interest
EN

250917 Delphi-2M Peter EN

Peter Bannister

Healthcare expert and Fellow at the Institution of Engineering and Technology

Science Media Centre UK

The authors have developed an AI model that is capable of accurately predicting disease and have shown that it works on data from the UK BioBank as well as nearly 2m people from Denmark. However, this is still a long way from improved healthcare as the authors acknowledge that both datasets are biased in terms of age, ethnicity, and current healthcare outcomes. While improved risk scores and the potential for precision medicine is an interesting future goal, the immediate challenge for healthcare is to ensure there is a sufficient digital infrastructure and skills base for everyone, regardless of socio-economic background, so the currently available technologies can be offered to those who most need improved access to treatments.

Declared CoI: Managing Director Romilly Life Sciences, Director of Life Sciences Hub Wales, Honorary Professor at the University of Birmingham. 

EN
Publications
Journal
Nature
Publication date
Authors

Artem Shmatko et al.

Study types:
  • Research article
  • Peer reviewed
  • People
  • Modelling
The 5Ws +1
Publish it
FAQ
Contact